Xenleta

Active Ingredient(s): Lefamulin Acetate
FDA Approved: * August 19, 2019
Pharm Company: * NABRIVA THERAPEUTICS US INC

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Xenleta Overview

Lefamulin (tradename Xenleta) is an antibiotic used it to treat adults with community-acquired bacterial pneumonia.[1] It is taken by mouth or by injection into a vein.[1][2] Relatively common side effects include diarrhea, nausea, pain at the site of injection, and liver inflammation.[1][3] It is a pleuromutilin antibiotic. Lefamulin was approved for medical use in the United States in 2019.[1] ...

Read more Xenleta Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Lefamulin

Recent Xenleta Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Lefamulin Acetate
  • Solution: 150mg/15ml (10mg/ml)
  • Tablet: 600mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Xenleta: (2 results)

Sorted by National Drug Code
  • 72000-110 Xenleta 600 mg Oral Tablet, Coated by Nabriva Therapeutics Us, Inc.
  • 72000-120 Xenleta 150 mg/15ml Intravenous Injection, Solution by Nabriva Therapeutics Us, Inc.

Other drugs which contain Lefamulin Acetate or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 11 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA